Expect to See Saxenda Used for Weight Loss in Adolescents
Saxenda (liraglutide) will be a new option to help tackle obesity in adolescents 12 and up...not just in adults.
About 30% of Canadian kids age 5 to 17 are overweight or obese. This may lead to adulthood obesity and a higher risk of health conditions...type 2 diabetes, heart disease, sleep apnea, etc.
The injectable med Saxenda has the same active ingredient as the diabetes med, Victoza. The big difference is that Saxenda is given in higher doses than Victoza...to help reduce hunger.